Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Approximately“
Suchtreffer
Begriffe & Kennungen
Dupixent · 4.8 · Approximately 16 % of adolescent patients with atopic dermatitis who received dupilumab 300 mg or 200 mg Q2W f
Eintrag öffnenDupixent · 4.8 · Approximately 4.7% of adult patients with CSU who received dupilumab 300 mg Q2W and adolescent patients with C
Eintrag öffnenDupixent · 4.8 · Approximately 5 % of patients with atopic dermatitis, asthma, or CRSwNP who received dupilumab 300 mg Q2W for
Eintrag öffnenDupixent · 4.8 · Approximately 5 % of patients with atopic dermatitis, asthma, or CRSwNP who received dupilumab 300 mg Q2W for
Eintrag öffnenDupixent · 4.8 · Approximately 8% of patients with COPD who received dupilumab 300 mg Q2W for 52 weeks developed antibodies to
Eintrag öffnenDupixent · 4.8 · Approximately 8% of patients with COPD who received dupilumab 300 mg Q2W for 52 weeks developed antibodies to
Eintrag öffnenDupixent · 4.8 · Approximately 9 % of patients with asthma who received dupilumab 200 mg Q2W for 52 weeks developed antibodies
Eintrag öffnenDupixent · 4.8 · Approximately 9 % of patients with asthma who received dupilumab 200 mg Q2W for 52 weeks developed antibodies
Eintrag öffnenEdarbi · 4.8 · Haemoglobin and haematocrit Small decreases in haemoglobin and haematocrit (mean decreases of approximately 3
Eintrag öffnenEmend · 4.5 · Corticosteroids Dexamethasone: The usual oral dexamethasone dose should be reduced by approximately 50 % when
Eintrag öffnenEmend · 4.5 · Corticosteroids Dexamethasone: The usual oral dexamethasone dose should be reduced by approximately 50 % when
Eintrag öffnenEmend · 4.8 · Summary of the safety profile The safety profile of aprepitant was evaluated in approximately 6,500 adults in
Eintrag öffnenEmend · 4.8 · Summary of the safety profile The safety profile of aprepitant was evaluated in approximately 6,500 adults in
Eintrag öffnenEnbrel · 4.8 · 103 month. Mean duration was approximately 3 to 5 days. No treatment was given for the majority of injection s
Eintrag öffnenEnbrel · 4.8 · In controlled trials in patients with plaque psoriasis, approximately 13.6% of patients treated with Enbrel de
Eintrag öffnenEnbrel · 4.8 · In controlled trials in patients with plaque psoriasis, approximately 13.6% of patients treated with Enbrel de
Eintrag öffnenEnbrel · 4.8 · In controlled trials in patients with plaque psoriasis, approximately 13.6% of patients treated with Enbrel de
Eintrag öffnenEnbrel · 4.8 · In controlled trials in patients with plaque psoriasis, approximately 13.6% of patients treated with Enbrel de
Eintrag öffnenEnbrel · 4.8 · In controlled trials in patients with plaque psoriasis, approximately 13.6% of patients treated with Enbrel de
Eintrag öffnenEnbrel · 4.8 · In controlled trials in patients with plaque psoriasis, approximately 13.6% of patients treated with Enbrel de
Eintrag öffnen